How Much Upside is Left in Ionis Pharmaceuticals (IONS)? Wall Street Analysts Think 55.91%
Portfolio Pulse from
Analysts predict a 55.9% upside for Ionis Pharmaceuticals (IONS) based on price targets. Despite the mixed reliability of this metric, the consensus on increased earnings estimates suggests potential stock growth.
December 11, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Ionis Pharmaceuticals (IONS) is projected to have a 55.9% upside according to analysts' price targets. The consensus on increased earnings estimates supports this potential growth.
The article highlights a significant potential upside for IONS based on analysts' price targets and consensus on earnings estimates. This suggests a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100